| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 943 | 713 | 21 |
| Full Text Views | 12 | 2 | 1 |
| PDF Downloads | 13 | 3 | 1 |
Disposition of Proguanil in Thai Patients with Uncomplicated Falciparum Malaria
M. D. Edstein
M. D. Edstein
Army Malaria Research Unit, Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Department of Immunology and Parasitology, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Sydney, Australia
Search for other papers by M. D. Edstein in
Current site
Google Scholar
PubMed
Search for other papers by M. D. Edstein in
Current site
Google Scholar
PubMed
S. Looareesuwan
S. Looareesuwan
Army Malaria Research Unit, Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Department of Immunology and Parasitology, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Sydney, Australia
Search for other papers by S. Looareesuwan in
Current site
Google Scholar
PubMed
Search for other papers by S. Looareesuwan in
Current site
Google Scholar
PubMed
P. Wilairatana
P. Wilairatana
Army Malaria Research Unit, Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Department of Immunology and Parasitology, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Sydney, Australia
Search for other papers by P. Wilairatana in
Current site
Google Scholar
PubMed
Search for other papers by P. Wilairatana in
Current site
Google Scholar
PubMed
S. Vanijanonta
S. Vanijanonta
Army Malaria Research Unit, Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Department of Immunology and Parasitology, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Sydney, Australia
Search for other papers by S. Vanijanonta in
Current site
Google Scholar
PubMed
Search for other papers by S. Vanijanonta in
Current site
Google Scholar
PubMed
D. E. Kyle
D. E. Kyle
Army Malaria Research Unit, Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Department of Immunology and Parasitology, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Sydney, Australia
Search for other papers by D. E. Kyle in
Current site
Google Scholar
PubMed
Search for other papers by D. E. Kyle in
Current site
Google Scholar
PubMed
K. H. Rieckmann
K. H. Rieckmann
Army Malaria Research Unit, Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Department of Immunology and Parasitology, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Sydney, Australia
Search for other papers by K. H. Rieckmann in
Current site
Google Scholar
PubMed
Search for other papers by K. H. Rieckmann in
Current site
Google Scholar
PubMed
The objective of this study was to examine the disposition of proguanil in malaria-infected Thai patients with acute uncomplicated falciparum malaria. Eleven patients were administered 500 mg of proguanil twice a day for three days (total dose = 3,000 mg). Four patients were tentatively classified as extensive metabolizers (EMs) and seven as poor metabolizers (PMs). The mean plasma clearances of proguanil for EMs and PMs were 1.31 and 1.10 L/hr/kg, respectively. The mean elimination half-life of proguanil was statistically longer in PMs than EMs (19.6 hr versus 16.1 hr; P = 0.01). Plasma clearance and elimination half-life of proguanil in the malaria patients were comparable with those reported in the literature for healthy Thai volunteers. In contrast to other ethnic groups, Thai EM patients had relatively low plasma concentrations of cycloguanil, the active metabolite of proguanil. None of the 11 patients treated with proguanil were cured of malaria and their phenotypic status did not affect the treatment outcome. Although high levels of parasite resistance to cycloguanil were probably responsible for the poor response to proguanil treatment, the inability of Thai EM and PM patients to produce cycloguanil may have also contributed to the treatment outcome.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 943 | 713 | 21 |
| Full Text Views | 12 | 2 | 1 |
| PDF Downloads | 13 | 3 | 1 |